| Financial Year |
March 31 2023 |
| Monetary Funds |
822,237,656.08 |
| Held-for-trading Financial Assets |
35,200,000.00 |
| Notes Receivable |
11,745,000.00 |
| Accounts Receivable |
495,288,034.51 |
| Advances to Suppliers |
34,469,034.34 |
| Other Receivables |
36,689,845.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
7,911,623.64 |
| Dividend Receivable |
-- |
| Inventories |
257,521,957.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,515,495.90 |
| Total Current Assets |
1,771,823,438.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,561,527.92 |
| Investment Properties |
164,072.67 |
| Fixed Assetes |
579,405,352.74 |
| Under-construction Projects |
49,883,192.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
429,825,005.27 |
| R&D expenses |
-- |
| Goodwill |
147,308,329.97 |
| Long-Term Deferred and Prepaid Expenses |
1,743,073.27 |
| Deferred Income Tax Assets |
11,350,118.01 |
| Other Non-Current Assets |
4,783,660.00 |
| Sub-Total of Non-Current Assets |
1,290,658,434.71 |
| Total Assets |
3,062,481,873.15 |
| Short-Term Loans |
436,735,044.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,562,000.00 |
| Accounts Payable |
293,968,040.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,816,144.69 |
| Taxes Payable |
18,063,407.42 |
| Interest Payable |
825,000.00 |
| Dividend Payable |
25,376,690.80 |
| Other payables |
252,795,749.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
97,428,850.89 |
| Other Current Liabilities |
6,820,981.84 |
| Sub-Total of Current Liabilities |
1,180,786,734.86 |
| Long-term Loans |
86,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
71,791.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,510,350.19 |
| Deferred Income Tax Liabilities |
47,253,414.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
201,842,259.11 |
| Total Liabilities |
1,382,628,993.97 |
| Paid-In Capital(Or Share Stock) |
347,614,197.00 |
| Capital Surplus |
794,780,912.14 |
| Surplus Reserve |
36,768,891.96 |
| LESS:Treasury Stock |
20,223,661.02 |
| Undistributed Profits |
272,412,874.11 |
| Minority Stockholder's Interest |
237,339,460.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,442,513,418.21 |
| Owner's Equity（Stockholder's Equity） |
1,679,852,879.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,062,481,873.15 |
